1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Grants for Junior Faculty / Postdoctoral Fellowships in Aging Research / Discovery Awards (multiple programs) is sponsored by American Federation for Aging Research (AFAR) & Glenn Foundation for Medical Research. AFAR, in partnership with the Glenn Foundation, offers several grant programs to advance biomedical research in aging.
These programs support a continuum of research from basic studies of model systems to early-stage translational research addressing human aging and health span. They aim to support promising investigators early in their careers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Programs are available for junior faculty and postdoctoral fellows, with an established national network with most research institutions in the U.S. Confirm the full requirements in the official notice before applying.
Grants for Junior Faculty / Postdoctoral Fellowships in Aging Research / Discovery Awards (multiple programs) is funded by American Federation for Aging Research (AFAR) & Glenn Foundation for Medical Research. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read article